title: Panel meeting prompts excitement for antiobesity drug.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010645:Phentermine / Q000009:adverse effects / Q000627:therapeutic use*; D000077236:Topiramate; D014481:United States
chemical_list: D019440:Anti-Obesity Agents; D004338:Drug Combinations; D000077236:Topiramate; D005632:Fructose; D010645:Phentermine